Klinik und Poliklinik für Geburtshilfe und Frauengesundheit
Klinikum / Johannes Gutenberg-Universität Mainz
Frees, Sebastian K.; Kamal, Mohammed M.; Nestler, Sebastian et al.
Risk-adjusted proposal for >60 months follow up after surgical treatment of organ-confined renal cell carcinoma according to life expectancyINTERNATIONAL JOURNAL OF UROLOGY. Bd. 26. H. 3. 2019 S. 385-390
Mayer, Sebastian; Iborra, Severine; Grimm, Donata et al.
Sexual activity and quality of life in patients after treatment for breast and ovarian cancerARCHIVES OF GYNECOLOGY AND OBSTETRICS. Bd. 299. H. 1. 2019 S. 191-201
Mavratzas, A.; Baek, S.; Gerber, B. et al.
Sorafenib in combination with docetaxel as first-line therapy for HER2-negative metastatic breast cancer: Final results of the randomized, double-blind, placebo-controlled phase II MADONNA studyBREAST. Bd. 45. 2019 S. 22-28
Elger, T; Krause, J; Hasenburg, A
Sport und Sexualität in der SchwangerschaftFrauenheilkunde up2date. Bd. 13. H. 4. 2019 S. 383-394
Schmidt, M
Stellungnahme der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG) e.V. zu Biomarkerbasierten Tests zur Entscheidung für oder gegen eine adjuvante systemische Chemotherapie beim primären MammakarzinomGeburtsh Frauenheilk. Bd. 79. 2019 S. 1254-1255
Loibl, s; Schmidt, M
Systemische Therapie bei endokrin empfindlichen KarzinomenUntch / Harbeck / Thomssen (Hrsg). Colloquium Senologie 2019/2020. München: LUKON Verlagsgesellschaft mbH 2019
Malsy, Manuela; Graf, Bernhard; Almstedt, Katrin
The active role of the transcription factor Sp1 in NFATc2-mediated gene regulation in pancreatic cancerBMC BIOCHEMISTRY. Bd. 20. 2019
Becker, Victoria Margaux; Silver, Saskia; Seufert, Rudolf et al.
The Association of Appendectomy, Adhesions, Tubal Pathology, and Female InfertilityJSLS-JOURNAL OF THE SOCIETY OF LAPAROENDOSCOPIC SURGEONS. Bd. 23. H. 1. 2019
Boutas, Ioannis; Potiris, Anastasios; Brenner, Walburgis et al.
The expression of galectin-3 in breast cancer and its association with chemoresistance: a systematic review of the literatureARCHIVES OF GYNECOLOGY AND OBSTETRICS. Bd. 300. H. 5. 2019 S. 1113-1120
Heller, Martin; Bauer, Heide-Katharina; Schwab, Roxana et al.
The impact of intercellular communication for the generation of complex multicellular prevascularized tissue equivalentsJOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A. 2019
Klapdor, Ruediger; Hillemanns, Peter; Woelber, Linn Lena et al.
The influence of obesity on tumor recurrence in vulvar cancer patients.JOURNAL OF CLINICAL ONCOLOGY. Bd. 37. H. 15. 2019
Staubach, P.; Schulz, S.; Zimmer, S. et al.
The Midwives as possible "Influencer" in AtopyJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 17. 2019 S. 71-71
Ditsch, Nina; Schmidt, Marcus
Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast CancerGEBURTSHILFE UND FRAUENHEILKUNDE. Bd. 79. H. 12. 2019 S. 1328-1335
Lebeau, A.; Denkert, C.; Sinn, P. et al.
Update of the German S3 breast cancer guideline. What is new for pathologists?PATHOLOGE. Bd. 40. H. 2. 2019 S. 185-198
Almstedt, K; Hasenburg, A
Wechseljahresbeschwerden – Hormonmangel nach der gynäko-onkologischen TherapieFrauenheilkunde up2date. Bd. 13. H. 5. 2019 S. 475-485
Schmalfeldt, Barbara; Brambs, Christine; Burges, Alexander et al.
What is the evidence for lymphadenectomy in presumed early ovarian cancer?ARCHIVES OF GYNECOLOGY AND OBSTETRICS. Bd. 299. H. 1. 2019 S. 1-5
Wiesmann, Nadine; Kluenker, Martin; Demut, Philipp et al.
Zinc overload mediated by zinc oxide nanoparticles as innovative anti-tumor agentJOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY. Bd. 51. 2019 S. 226-234
Verhoeven, Carole; Schmidt, Marcus; Hoenig, Arnd et al.
(E)stetrol for treatment of advanced ER+ breast cancerCANCER RESEARCH. Bd. 78. H. 4. 2018
Surowy, Harald; Varga, Dominic; Burwinkel, Barbara et al.
A low-frequency haplotype spanning SLX4/FANCP constitutes a new risk locus for early-onset breast cancer (< 60 years) and is associated with reduced DNA repair capacityINTERNATIONAL JOURNAL OF CANCER. Bd. 142. H. 4. 2018 S. 757-768
Kebenko, Maxim; Goebeler, Marie-Elisabeth; Wolf, Martin et al.
A multicenter phase 1 study of solitomab (MT110, AMG 110), a bispecific EpCAM/CD3 T-cell engager (BiTE (R)) antibody construct, in patients with refractory solid tumorsONCOIMMUNOLOGY. Bd. 7. H. 8. 2018
Schmidt, Marcus; Decker, Thomas; Fehm, Tanja et al.
A phase II study of metronomic daily oral vinorelbine as first-line chemotherapy in advanced/metastatic hormone receptor positive (HR plus ) / human epidermal growth factor receptor 2 negative (HER2-) breast cancer resistant to endocrine therapy - VinoMetroCANCER RESEARCH. Bd. 78. H. 4. 2018
Coombes, R. C.; Tovey, Holly; Kilburn, Lucy et al.
A phase III multicentre double blind randomised trial of celecoxib versus placebo in primary breast cancer patients (REACT - Randomised EuropeAn celecoxib trial)CANCER RESEARCH. Bd. 78. H. 4. 2018
Mueller, V.; Park-Simon, T. -W.; Huober, J. et al.
A randomized, double-blinded pivotal study of tucatinib (ONT-380) vs. placebo in combination with capecitabine and trastuzumab in patients with pretreated HER2-pos. unresectable locally advanced or metastatic breast cancer: HER2CLIMBONCOLOGY RESEARCH AND TREATMENT. Bd. 41. 2018 S. 28-28
Loibl, Sibylle; Barinoff, Jana; Seiler, Sabine et al.
A randomized, open-label, multi-center phase IV study evaluating palbociclib plus endocrine treatment versus a chemotherapy-based treatment strategy in patients with hormone receptor-positive, HER2-negative metastatic breast cancer in a real world setting (PADMA)CANCER RESEARCH. Bd. 78. H. 4. 2018
Heimes, Anne-S.; Jaekel, J.; Weyer-Elberich, V. et al.
A retrospective analysis of immunohistochemically determined IRF4 expression in a consecutive cohort of 114 ovarian cancer patientsONCOLOGY RESEARCH AND TREATMENT. Bd. 41. 2018 S. 92-92
Thill, Marc; Liedtke, Cornelia; Mueller, Volkmar et al.
AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2018BREAST CARE. Bd. 13. H. 3. 2018 S. 209-215
Weikel, W
Aspekte der RehabilitationSchnürch, Hampl, Wöler (Hrsg). Tumorerkrankungen der Vulva und Vagina. 1. Aufl. Berlin: Springer 2018
Frees, S; Breuksch, I; Haber, T et al.
Calcium-sensing receptor (CaSR) promotes development of bone metastasis in renal cell carcinomaOncotarget. Bd. 16. H. 1. 2018 S. 35
Merzenich, Hiltrud; Blettner, Maria; Niehoff, Dorothea et al.
Cardiac late events in German breast cancer patients: a validation study on the agreement between patient self-reports and information from physiciansBMC CARDIOVASCULAR DISORDERS. Bd. 18. 2018
Thaler, Sonja; Schad, Arno; Kirkpatrick, Charles James et al.
Cellular senescence within HER2-amplified breast cancer: Potential implications for breast cancer immune surveillance and HER2-targeted therapy resistanceCANCER RESEARCH. Bd. 78. H. 4. 2018
Bartlett, John M. S.; Bayani, Jane; Kornaga, Elizabeth et al.
Comparative survival analysis of multiparametric tests in the TEAM pathology study: What to do when molecular tests disagree?CANCER RESEARCH. Bd. 78. H. 4. 2018
Bayani, Jane; Kornaga, Elizabeth N.; Crozier, Cheryl et al.
Copy-number and targeted sequencing analyses to identify distinct prognostic groups: Implications for patient selection to targeted therapies amongst anti-endocrine therapy resistant early breast cancersCANCER RESEARCH. Bd. 78. H. 4. 2018
Bayani, Jane; Crozier, Cheryl; Quintayo, Mary Anne et al.
Evaluation of the oncomine comprehensive assay for the identification of actionable mutations for therapeutic stratification from the TEAM pathology cohortCANCER RESEARCH. Bd. 78. H. 4. 2018
Krajnak, Slavomir; Battista, Marco; Brenner, Walburgis et al.
Explorative Analysis of Low-Dose Metronomic Chemotherapy with Cyclophosphamide and Methotrexate in a Cohort of Metastatic Breast Cancer PatientsBREAST CARE. Bd. 13. H. 4. 2018 S. 272-276
Galetzka, D.; Boeck, J.; Dittrich, M. et al.
Factors leading to changes in methylation of intron 2 in RAD9A gene and their possible influence in tumor developmentSTRAHLENTHERAPIE UND ONKOLOGIE. Bd. 194. 2018 S. S56-S56
Huebner, Hanna; Fasching, Peter A.; Gumbrecht, Walter et al.
Filtration based assessment of CTCs and CellSearch (R) based assessment are both powerful predictors of prognosis for metastatic breast cancer patientsBMC CANCER. Bd. 18. 2018
Honecker, Friedemann; Harbeck, Nadia; Schnabel, Claudia et al.
Geriatric assessment and biomarkers in patients with metastatic breast cancer receiving first-line mono-chemotherapy: Results from the randomized phase III PELICAN trialJOURNAL OF GERIATRIC ONCOLOGY. Bd. 9. H. 2. 2018 S. 163-169
Pradella, F.; Leimer, B.; Fruth, A. et al.
Health effects of in utero exposure to Ramadan: A survey study among pregnant Muslim women in GermanyEUROPEAN JOURNAL OF PUBLIC HEALTH. Bd. 28. 2018 S. 487-487
Hasenburg, A.; Harter, P.; Park-Simon, T-W. et al.
Health-related quality of life (HRQOL) and patient-centered outcomes with maintenance olaparib compared with placebo following chemotherapy in patients with germline BRCA-mutated platinum-sensitive relapsed serous ovarian cancer: SOLO2 Phase IIIONCOLOGY RESEARCH AND TREATMENT. Bd. 41. 2018 S. 88-89
Almstedt, K; Schmidt, M
Immuno-oncology in breast cancer – from diagnosis to therapychirurgische praxis. Bd. 83. 2018 S. 674-680
Almstedt, K; Schmidt, M
Immunonkologie beim Mammakarzinom - von der Diagnose bis zur Therapiegyne. Bd. 39. 2018 S. 20-24
Derks, M. G. M.; Bastiaannet, E.; van de Water, W. et al.
Impact of age on breast cancer mortality and competing causes of death at 10 years follow-up in the adjuvant TEAM trialEUROPEAN JOURNAL OF CANCER. Bd. 99. 2018 S. 1-8
Breuksch, Ines; Welter, Jonas; Bauer, Heide-Katharina et al.
In renal cell carcinoma the PTEN splice variant PTEN-Delta shows similar function as the tumor suppressor PTEN itselfCELL COMMUNICATION AND SIGNALING. Bd. 16. 2018
Pleimes, Dirk; Moebus, Volker; Mayer, Frank et al.
Induced Myerosuppression and Recommendation for Monitoring of Absolute Neutrophil Counts in Patients Treated with Epirubicin and Cyclophosphamide in Early Breast Cancer: Results from a Phase 2a Collaborative Trial of the AGO-B and CESAR Study GroupsBLOOD. Bd. 132. 2018
Woeckel, Achim; Festl, Jasmin; Stueber, Tanja et al.
Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast CancerGEBURTSHILFE UND FRAUENHEILKUNDE. Bd. 78. H. 10. 2018 S. 927-947
Woeckel, Achim; Festl, Jasmin; Stueber, Tanja et al.
Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast CancerGEBURTSHILFE UND FRAUENHEILKUNDE. Bd. 78. H. 11. 2018 S. 1056-1088
Reimer, Toralf; Engel, Jutta; Schmidt, Marcus et al.
Is Axillary Sentinel Lymph Node Biopsy Required in Patients Who Undergo Primary Breast Surgery?BREAST CARE. Bd. 13. H. 5. 2018 S. 324-330
Bartkowiak, D.; Buehrdel, S.; Wiegel, T. et al.
Lack of evidence for cardiac effects of breast cancer irradiationSTRAHLENTHERAPIE UND ONKOLOGIE. Bd. 194. 2018 S. S82-S83
Bartkowiak, D.; Buehrdel, S.; Wiegel, T. et al.
Lack of evidence for cardiac effects of breast cancer irradiationSTRAHLENTHERAPIE UND ONKOLOGIE. Bd. 194. 2018 S. S82-S83
Merzenich, Hiltrud; Wollschlaeger, Daniel; Almstedt, Katrin et al.
Late cardiac effects after radiotherapy and chemotherapyONKOLOGE. Bd. 24. H. 10. 2018 S. 780-789
Hasenburg, Annette; Sehouli, Jalid; Lampe, Boern et al.
LION-PAW: Lymphadenectomy in ovarian neoplasm-pleasure ability of women-Prospective substudy of the randomized multicenter LION study.JOURNAL OF CLINICAL ONCOLOGY. Bd. 36. H. 15. 2018
Reinisch, M.; Seiler, S.; Hauzenberger, T. et al.
Male-GBG54: A prospective, randomised multi-centre phase II study evaluating endocrine treatment with either tamoxifen plus /- gonadotropin releasing hormone analogue (GnRHa) or an aromatase inhibitor plus GnRHa in male breast cancer patientsCANCER RESEARCH. Bd. 78. H. 4. 2018
Thill, Marc; Schmidt, Marcus
Management of adverse events during cyclin-dependent kinase 4/6 (CDK4/6) inhibitor-based treatment in breast cancerTHERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY. Bd. 10. 2018
Eckes, L.; Droge, L. A.; Fullborn, T. et al.
Management of patients with gynecological sarcoma - a survery among gynecologists within the framework of the German Registry of Gynecological Sarcoma (REGSA)ONCOLOGY RESEARCH AND TREATMENT. Bd. 41. 2018 S. 194-195
Moebus, Volker; Noeding, Stefanie; Ladda, Ekkehart et al.
Neo-/adjuvant phase III trial to compare intense dose-dense (idd) treatment with EnPC to tailored dose-dense (dt) therapy with dtEC-dtD for patients with high-risk early breast cancer: Results on pathological complete response (pCR) for patients treated within the neoadjuvant setting.JOURNAL OF CLINICAL ONCOLOGY. Bd. 36. H. 15. 2018
Ackermann, S; Dannecker, C; Horn, L-C et al.
Operative Therapie des PrimärtumorsSchnürch, Hampl, Wöler (Hrsg). Tumorerkrankungen der Vulva und Vagina. 1. Aufl. Berlin: Springer 2018
de Gregorio, N.; Harter, P.; Kimmig, R. et al.
Overall survival results of AGO-OVAR 12, a randomized placebo-controlled multinational phase III trial with chemotherapy plus /- nintedanib in patients with advanced primary ovarian cancerONCOLOGY RESEARCH AND TREATMENT. Bd. 41. 2018 S. 88-88
Schmidt, M; Sebastian, M
Palbociclib -The First of a New Class of Cell Cycle InhibitorsRecent Results Cancer Res. Bd. 211. 2018 S. 153-175
Schmidt, M; Sebastian, M
Palbociclib – the first of a new class of cell cycle inhibitors. In Small Molecules in OncologyMartens (Hrsg). Small Molecules in Oncology. Springer 2018
Schmidt, M.; Gerlach, C.
Palliative medical measures for gynecological malignancies and breast cancer according to S3 guidelinesGYNAKOLOGE. Bd. 51. H. 10. 2018 S. 859-869
Kreipe, H; Schmidt, M
Pathologie, Prognose und PrädiktionColloquium Senologie 2018/2019. München: Agileum Verlagsgesellschaft mbH 2018
Mobus, V.; Mahlberg, R.; Janni, W. et al.
Pharmacokinetic results of a subcutaneous injection of trastuzumab into the thigh versus into the abdominal wall in patients with HER2-positive primary breast cancer (BC) treated within the neo-/adjuvant GAIN-2 studyCANCER RESEARCH. Bd. 78. H. 4. 2018
Hillemanns, P.; Sehouli, J.; Harter, P. et al.
Phase III Randomized Controlled Study to Evaluate the Impact of Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer - AGO Desktop III / ENGOT OV20ONCOLOGY RESEARCH AND TREATMENT. Bd. 41. 2018 S. 11-11
Seeger, A
Plastische Rekonstruktion der VaginaSchnürch, Hampl, Wöler (Hrsg). Tumorerkrankungen der Vulva und Vagina. 1. Aufl. Berlin: Springer 2018
Hampl, M; Weikel, W
Plastische Rekonstruktion der VulvaSchnürch, Hampl, Wöler (Hrsg). Tumorerkrankungen der Vulva und Vagina. 1. Aufl. Berlin: Springer 2018
Singer, Susanne; Claus, Sylke; Briest, Susanne et al.
Positive and negative changes in life after cancer diagnosis. A prospective mixed-methods studyONKOLOGE. Bd. 24. H. 5. 2018 S. 411-419
Roseweir, Antonia K.; Bennett, Lindsay; Dickson, Ashley et al.
Predictive Biomarkers for Endocrine Therapy: Retrospective Study in Tamoxifen and Exemestane Adjuvant Multinational (TEAM) TrialJNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. Bd. 110. H. 6. 2018 S. 616-627
Schwab, R.; Rautenberg, B.; Weis, J. et al.
Pregnancy and cancer: psycho-oncological counseling on fertilityONKOLOGE. Bd. 24. H. 7. 2018 S. 552-555
Lorenz, Eva; Blettner, Maria; Lange, Bjoern et al.
Prevalence of Cardiac Disease in Breast Cancer Patients at Time of Diagnosis Compared to the General Female Population in GermanyBREAST CARE. Bd. 13. H. 4. 2018 S. 264-271
Hasenburg, A.
Primary Therapy of Ovarian CancerGYNAKOLOGE. Bd. 51. H. 8. 2018 S. 598-598
Schmidt, Marcus; Weyer-Elberich, Veronika; Hengstler, Jan G. et al.
Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient populationBREAST CANCER RESEARCH. Bd. 20. 2018
Bartkowiak, D.; Merzenich, H.; Wollschlager, D. et al.
Results from the PASSOS heart studyONCOLOGY RESEARCH AND TREATMENT. Bd. 41. 2018 S. 1-1
Hartmann, Kerstin; Schlombs, Kornelia; Laible, Mark et al.
Robustness of biomarker determination in breast cancer by RT-qPCR: impact of tumor cell content, DCIS and non-neoplastic breast tissueDIAGNOSTIC PATHOLOGY. Bd. 13. 2018
Feiten, Stefan; Scholl, Isabelle; Schmidt, Marcus et al.
Shared decision making (SDM) in routine care treatment of breast cancer patients - a survey of patients following surgeryCANCER RESEARCH. Bd. 78. H. 4. 2018
Bartlett, John M. S.; Thomas, Jeremy; Mallon, Elizabeth et al.
Simplified histological grading of breast carcinoma - potential for improved concordance and consistency in breast cancer grading?CANCER RESEARCH. Bd. 78. H. 4. 2018
Chekerov, Radoslav; Hilpert, Felix; Mahner, Sven et al.
Sorafenib plus topotecan versus placebo plus topotecan for platinum-resistant ovarian cancer (TRIAS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trialLANCET ONCOLOGY. Bd. 19. H. 9. 2018 S. 1247-1258
Loibl, S; Schmidt, M
Systemische Therapie bei endokrin empfindlichen KarzinomenColloquium Senologie 2018/2019. München: Agileum Verlagsgesellschaft mbH 2018
Kiweler, Nicole; Brill, Boris; Wirth, Matthias et al.
The histone deacetylases HDAC1 and HDAC2 are required for the growth and survival of renal carcinoma cellsARCHIVES OF TOXICOLOGY. Bd. 92. H. 7. 2018 S. 2227-2243
Thill, Marc; Schmidt, Marcus; Lux, Michael et al.
The Introduction and Use of biosimilar Antibodies in the Treatment of Breast CancerGEBURTSHILFE UND FRAUENHEILKUNDE. Bd. 78. H. 1. 2018 S. 41-44
Huss, Alexandra; Ihorst, Gabriele; Timme-Bronsert, Sylvia et al.
The Memorial Sloan Kettering Cancer Center Nomogram is More Accurate than the 2009 FIGO Staging System in the Prediction of Overall Survival in a German Endometrial Cancer Patient CohortANNALS OF SURGICAL ONCOLOGY. Bd. 25. H. 13. 2018 S. 3966-3973
Heitz, F.; Harter, P.; Kimmig, R. et al.
The prognostic value of tumor residuals (TR) indicated by surgeon (SA), by radiology (RA), or an integrated approach (IA) by surgeons' assessment and pre-chemotherapy CT-scan in patients with advanced ovarian cancer: An exploratory analysis of the AGO led Intergroup trial AGO-OVAR 12ONCOLOGY RESEARCH AND TREATMENT. Bd. 41. 2018 S. 12-12
Witzel, I.; Laakmann, E.; Weide, R. et al.
Treatment and outcomes of patients in the Brain Metastases in Breast Cancer Network RegistryEUROPEAN JOURNAL OF CANCER. Bd. 102. 2018 S. 1-9
de Boniface, Jana; Schmidt, Marcus; Engel, Jutta et al.
What Is the Best Management of cN0pN1(sn) Breast Cancer Patients?BREAST CARE. Bd. 13. H. 5. 2018 S. 331-336
Muenster, Eva; Letzel, Stephan; Passet-Wittig, Jasmin et al.
Who is the gate keeper for treatment in a fertility clinic in Germany? -baseline results of a prospective cohort study (PinK study)-BMC PREGNANCY AND CHILDBIRTH. Bd. 18. 2018
Merzenich, Hiltrud; Bartkowiak, Detlef; Schmidberger, Heinz et al.
3D conformal radiotherapy is not associated with the long-term cardiac mortality in breast cancer patients: a retrospective cohort study in Germany (PASSOS-Heart Study)BREAST CANCER RESEARCH AND TREATMENT. Bd. 161. H. 1. 2017 S. 143-152
Schwab, R.; Battista, M. J. B.; Kuenzel, K. et al.
A CASE OF UTERINE RELAPSE IN A YOUNG WOMAN WITH A HISTORY OF ALL (ACUTE LYMPHOBLASTIC LEUKEMIA)INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. Bd. 27. 2017 S. 995-995
Thomssen, Christoph; Decker, Thomas; Fehm, Tanja et al.
A PHASE II STUDY OF METRONOMIC DAILY ORAL VINORELBINE AS FIRST-LINE CHEMOTHERAPY IN ADVANCED/METASTATIC HORMONE RECEPTOR POSITIVE (HR plus )/HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 NEGATIVE (HER2-) BREAST CANCER RESISTANT TO ENDOCRINE THERAPY: VINOMETROBREAST. Bd. 36. 2017 S. S51-S51
Harbeck, Nadia; Saupe, Steffen; Jaeger, Elke et al.
A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN studyBREAST CANCER RESEARCH AND TREATMENT. Bd. 161. H. 1. 2017 S. 63-72
Loibl, Sibylle; Barinoff, Jana; Seiler, Sabine et al.
A randomized, open-label, multicentre, phase IV study evaluating palbociclib plus endocrine treatment versus a chemotherapy based treatment strategy in patients with hormone receptor positive/HER2-negative metastatic breast cancer in a real world settingJOURNAL OF CLINICAL ONCOLOGY. Bd. 35. 2017
Heimes, A. S.; Schmidt, M.; Jaekel, J. et al.
A RETROSPECTIVE ANALYSIS OF IMMUNOHISTOCHEMICAL DETERMINED IRF4 (INTERFERON REGULATING FACTOR 4) EXPRESSION IN A CONSECUTIVE COHORT OF 114 OVARIAN CANCER PATIENTSINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. Bd. 27. 2017 S. 1520-1520
Thill, Marc; Liedtke, Cornelia; Solomayer, Erich-Franz et al.
AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2017BREAST CARE. Bd. 12. H. 3. 2017 S. 184-191
Makris, Georgios-Marios; Marinelis, Alexandros; Battista, Marco-Johannes et al.
An ovarian mass after breast cancer: Metachronous carcinoma or metastasis? A case reportINTERNATIONAL JOURNAL OF SURGERY CASE REPORTS. Bd. 31. 2017 S. 106-108
Fasching, Peter A.; Grischke, Eva -Maria; Schuetz, Florian et al.
Analysis of everolimus starting dose as prognostic marker in HR plus mBC patients treated with everolimus (EVE) plus exemestane (EXE): Results of the 3rd interim analysis of the non-interventional trial BRAWO.JOURNAL OF CLINICAL ONCOLOGY. Bd. 35. 2017
Frees, Sebastian; Kamal, Mohammed; Nestler, Sebastian et al.
ARE THE CURRENT FOLLOW-UP GUIDELINES AFTER TREATMENT FOR ORGAN CONFINED RENAL CANCER SUFFICIENT?JOURNAL OF UROLOGY. Bd. 197. H. 4. 2017 S. E914-E914
Moebus, Volker; Hell, Susanne; Schmidt, Marcus
Assessing the Clinical Benefit of Systemic Adjuvant Therapies for Early Breast CancerGEBURTSHILFE UND FRAUENHEILKUNDE. Bd. 77. H. 10. 2017 S. 1079-1087
Maurer, S.; Elger, T.; Krajnak, S. et al.
AXILLARY SCHWANNOMA IMITATING AXILLARY CYSTINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. Bd. 27. 2017 S. 1298-1298
Battista, M. J.; Schanz, V.; Schmidt, M. et al.
CHANGES OF THE THERAPEUTIC APPROACHES FOR ENDOMETRIAL CANCER PATIENTS IN GERMANY SINCE 2006INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. Bd. 27. 2017 S. 1041-1041
Bayani, Jane; Kornaga, Elizabeth; Crozier, Cheryl et al.
Copy-number and targeted sequencing analyses to identify distinct prognostic groups: Implications for patient selection to targeted therapies amongst anti-endocrine therapy resistant early breast cancers.JOURNAL OF CLINICAL ONCOLOGY. Bd. 35. 2017
Baumann, F. T.; Hasenburg, A.; Jahn, P. et al.
Excercise is medicine in oncology. On the way to becoming a standard pillar in the treatment of cancer patientsONKOLOGE. Bd. 23. H. 12. 2017 S. 1021-1030
Eckes, L.; Harter, P.; Muallem, M. Z. et al.
FIRST RESULTS OF THE GERMAN PROSPECTIVE REGISTRY FOR GYNECOLOGICAL SARCOMAS (REGSA): A COLLABORATION OF NOGGO, AGO STUDY GROUP, AGO KOMMISSION OVAR, AGO KOMMISSION UTERUS, AROINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. Bd. 27. 2017 S. 1323-1323